These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 22126559)
1. Survival and prognostic factors comparing stage IB 1 versus stage IB 2 cervical cancer treated with primary radical hysterectomy. Srisomboon J; Kietpeerakool C; Suprasert P; Manopanya M; Siriaree S; Charoenkwan K; Cheewakriangkrai C; Sae-Teng C Asian Pac J Cancer Prev; 2011; 12(7):1753-6. PubMed ID: 22126559 [TBL] [Abstract][Full Text] [Related]
2. Twelve years experience with radical hysterectomy and pelvic lymphadenectomy in early stage cervical cancer. Suprasert P; Srisomboon J; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Kietpeerakool C; Phongnarisorn C; Sae-Teng J J Obstet Gynaecol; 2010 Apr; 30(3):294-8. PubMed ID: 20373935 [TBL] [Abstract][Full Text] [Related]
3. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors]. Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686 [TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy. Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728 [TBL] [Abstract][Full Text] [Related]
5. Locoregional spread and survival of stage IIA1 versus stage IIA2 cervical cancer. Hongladaromp W; Tantipalakorn C; Charoenkwan K; Srisomboon J Asian Pac J Cancer Prev; 2014; 15(2):887-90. PubMed ID: 24568513 [TBL] [Abstract][Full Text] [Related]
6. Ten-year survival of patients with locally advanced, stage ib-iib cervical cancer after neoadjuvant chemotherapy and radical hysterectomy. Hwang YY; Moon H; Cho SH; Kim KT; Moon YJ; Kim SR; Kim DS Gynecol Oncol; 2001 Jul; 82(1):88-93. PubMed ID: 11426967 [TBL] [Abstract][Full Text] [Related]
7. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy. Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655 [TBL] [Abstract][Full Text] [Related]
8. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa]. Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669 [TBL] [Abstract][Full Text] [Related]
9. Outcome of cervical cancer patients with single-node compared with no nodal involvement treated with radical hysterectomy and pelvic lymphadenectomy. Suprasert P; Charoenkwan K; Siriaree S; Cheewakriangkrai C; Saeteng J; Srisomboon J Int J Gynaecol Obstet; 2013 Apr; 121(1):45-8. PubMed ID: 23343573 [TBL] [Abstract][Full Text] [Related]
10. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma. Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837 [TBL] [Abstract][Full Text] [Related]
11. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery. Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418 [TBL] [Abstract][Full Text] [Related]
12. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran. Behtash N; Karimi Zarchi M; Deldar M Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880 [TBL] [Abstract][Full Text] [Related]
13. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Tsai CS; Lai CH; Wang CC; Chang JT; Chang TC; Tseng CJ; Hong JH Gynecol Oncol; 1999 Dec; 75(3):328-33. PubMed ID: 10600284 [TBL] [Abstract][Full Text] [Related]
15. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix. Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659 [TBL] [Abstract][Full Text] [Related]
16. Pelvic node removal and disease-free survival in cervical cancer patients treated with radical hysterectomy and pelvic lymphadenectomy. Suprasert P; Charoenkwan K; Khunamornpong S Int J Gynaecol Obstet; 2012 Jan; 116(1):43-6. PubMed ID: 21978816 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Gadducci A; Teti G; Barsotti C; Tana R; Fanucchi A; Orlandini C; Fabrini MG; Genazzani AR Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636 [TBL] [Abstract][Full Text] [Related]
18. Recurrence patterns after radical hysterectomy in stage IB1-IIA cervical. Sittidilokratna K; Cheewakriangkrai C; Khunamornpong S; Siriaunkgul S Asian Pac J Cancer Prev; 2010; 11(2):499-502. PubMed ID: 20843140 [TBL] [Abstract][Full Text] [Related]
19. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients. Zheng M; Huang L; Liu JH; Xiong Y; Li JD; Huang X; He L; Ren YF; Wang HY J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358 [TBL] [Abstract][Full Text] [Related]
20. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Lai CH; Hong JH; Hsueh S; Ng KK; Chang TC; Tseng CJ; Chou HH; Huang KG Cancer; 1999 Apr; 85(7):1537-46. PubMed ID: 10193944 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]